Tillotts Pharma specialises in one area of therapy, diseases of the lower gastrointestinal tract.
The products that Tillotts is responsible for treat two disease conditions:

* inflammatory bowel disease (IBD)
* irritable bowel syndrome (IBS)

SALES & MARKETING
Tillotts markets two brands:

* Asacol®, which through the efforts of licensees and distributors has become the leading product worldwide for the treatment of Inflammatory Bowel Disease (IBD), consisting of Crohn's disease and ulcerative colitis, and
*
Colpermin®, a naturally based remedy for the treatment of symptoms of Irritable Bowel Syndrome (IBS).

5-ASA
Asacol
Colpermin
Crohn's disease
Epanova
IBD
IBS
Inflammatory bowel disease
Irritable bowel syndrome
Mesalazine
Peppermint oil
Tillotts
Ulcerative Colitis
Topasa

Tillotts is a small, fast growing pharmaceutical company based near Basel, in Switzerland.

  MANAGEMENT OF IRRITABLE BOWEL SYNDROME  
     
  TREATMENT OF IBS
Once IBS has been diagnosed, the available treatments have to be evaluated and discussed to find the most suitable therapy for each patient.

 

Depending on the severity and kind of symptoms IBS treatment can include:

  • Antispasmodics
  • Antiflatulents
  • Antidiarrhoeals
  • 5HT4 receptor agonists/5HT3 receptor antagonists
  • Laxatives
  • Antidepressants
  • Hypnotherapy


It is advisable to include a change of lifestyle in the therapy. Practicing a healthier lifestyle and reducing the amount of stress and anxiety in daily life should help to reduce the symptoms of IBS. Physical activity alleviates tension. Relaxation exercises, regular meals and a balanced diet can improve the quality of life. Avoiding trigger foods and drinking plenty of water will also help reduce the symptoms of IBS.

 

Trigger foods:

  • dietary fiber
  • chocolate
  • caffeine
  • alcohol
  • fatty food
  • sweeteners
  • milk products


IMPORTANT NOTICE

IBS is not life threatening! It is important to realise that people suffering from IBS are no more likely to develop other gastrointestinal diseases such as ulcerative colitis, Crohn’s disease or colon cancer than healthy individuals.

    
© 2007 by tillotts pharma ag – all rights reserved | designed by senger interactive
   photos: keystone science (visual) | tillotts pharma ag